First Turn Management »

Silverback Therapeutics shares owned by First Turn Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.6M 593k 14.50

More positions owned by First Turn Management

Nuvalent Inc-a (NUVL)
Argenx Se Sponsored Adr (ARGX)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Vaxcyte (PCVX)
Axsome Therapeutics (AXSM)
Syndax Pharmaceuticals (SNDX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Natera (NTRA)
Intra Cellular Therapies (ITCI)
Crinetics Pharmaceuticals In (CRNX)
Transmedics Group (TMDX)
Arcellx Common Stock (ACLX)
Blueprint Medicines (BPMC)
Verona Pharma Sponsored Ads (VRNA)

View all positions for First Turn Management

Top funds holding Silverback Therapeutics

Deerfield Management Company
RA Capital Management
OrbiMed Advisors
BlackRock
Sr One Capital Management
Vanguard Group
Franklin Resources
State Street Corporation
Geode Capital Management
Nextech Invest
FMR
Woodline Partners
Royce & Associates
Jacobs Levy Equity Management
First Turn Management

View all funds holding Silverback Therapeutics